2023年度淋巴瘤诊断和治疗进展OACSTPCD
Progress in the diagnosis and treatment of lymphoma in 2023
淋巴瘤是一组起源于淋巴细胞的恶性肿瘤,有90多个亚型.传统上分为非霍奇金淋巴瘤和霍奇金淋巴瘤.近年来的研究改变了淋巴瘤现有的治疗格局,不同亚型淋巴瘤的治疗方案有所不同.本文旨在综述2023年度淋巴瘤诊断和治疗进展.
Lymphoma is a group of malignant neoplasms of lymphocytes with more than 90 subtypes.It is traditionally classified broadly as non-Hodgkin lymphoma or Hodgkin lymphoma.Several recent advances have affected the treatment landscape,different subtypes of lymphoma have different treatment options.In this paper we aim to review the progress in diagnosis and treatment of lymphoma in 2023.
陈婷婷;李志铭
中山大学肿瘤防治中心 内科,广东 广州 510060中山大学肿瘤防治中心 内科,广东 广州 510060
非霍奇金淋巴瘤霍奇金淋巴瘤淋巴细胞治疗进展
Non-Hodgkin lymphomaHodgkin lymphomaLymphocytesTreatment progress
《肿瘤综合治疗电子杂志》 2024 (2)
59-68,10
评论